Pinned straw:
I’m quite relaxed about it, although the sugar hit of the pop is nice.
They are sufficiently funded to get their pre-wired Telehealth channel running, but probably not if they also want boots on the ground.
in addition, there are other products in the portfolio that require clinical development, and now with cashflows in sight, they can move on to the next of these.
I am curious to see what the proposed uses of the cash are. I also hope there will be an SPP, but I’ve got my suspicions that retail holders might not be included if they want to get it done quick. :-(
Attention now turns to what the revenue scenarios are, which is a nice change from thinking about the 90%/10% binary approval.
I’m quite relaxed about it, although the sugar hit of the pop is nice.
They are sufficiently funded to get their pre-wired Telehealth channel running, but probably not if they also want boots on the ground.
in addition, there are other products in the portfolio that require clinical development, and now with cashflows in sight, they can move on to the next of these.
I am curious to see what the proposed uses of the cash are. I also hope there will be an SPP, but I’ve got my suspicions that retail holders might not be included if they want to get it done quick. :-(
Attention now turns to what the revenue scenarios are, which is a nice change from thinking about the 90%/10% binary approval.
Also the last time there was a capital raise by Botanix, retail shareholders were not offered the opportunity to participate. The cynic in me wonders if this will be the case again and the insto's will be purely looking after themselves. Great news but still very interesting times ahead for holders.